News

kuhp.kyoto-u.ac.jp Objectives We sought to evaluate the prognostic impact of the B-type natriuretic peptide (BNP) levels in patients with asymptomatic severe aortic stenosis (AS), who were not ...
And so this is shown in a current ACCHA guideline, 2A guideline which says that patients with asymptomatic severe high-gradient aortic stenosis who have a BNP that's over three times normal may be ...
Unfortunately, BNP was not included in the clinical scoring system due ... The RECOVERY (Randomized Comparison of Early Surgeryversus Conventional Treatment in Very Severe Aortic Stenosis) trial ...
very severe aortic stenosis defined by a peak velocity>5.5 m/s, (2) severe valve calcification and a rate of peak velocity progression≥0.3 m/s/year, (3) markedly elevated brain natriuretic peptide ...
Aortic stenosis is a progressive and potentially fatal condition, affecting about five per cent of 65-year-olds in the US -- with increasing prevalence in advancing age. Symptoms include chest ...
Edwards Lifesciences (NYSE: EW) today announced new economic and clinical evidence on severe aortic stenosis (AS).
Once again, data are suggesting that operators should move cautiously in bicuspid anatomy and think about surgery first.
The benefit of TAVR vs. clinical surveillance for patients with asymptomatic severe aortic stenosis did not vary by age. TAVR was tied to lower stroke risk in the youngest and oldest age groups.
Aortic stenosis happens when your aortic valve does not open all the way causing pressure to build in the left ventricle. This pressure blocks blood flow as it leaves the heart. In other words, the ...
for patients with severe aortic stenosis even without symptoms. This is the first FDA approval for TAVR in patients who are asymptomatic. Current clinical guidelines recommend routine surveillance ...
Aortic stenosis is a progressive and potentially fatal condition, affecting an estimated 300,000 people in the UK. It affects about five per cent of 65-year-olds in the US, with increasing ...
in patients with aortic stenosis (AS), according to data from the PREFER-CMR registry. The findings are encouraging in the context of the recent approval of TAVI for patients with asymptomatic severe ...